Antioxidants meet molecular targets for cancer prevention and therapeutics

Area of Science:

• Biochemistry
• Oncology
• Nutritional Science

Background:

• Oxidant-antioxidant balance is vital for biological systems; deregulation contributes to diseases, including cancer.
• Antioxidants, particularly natural and diet-based agents, have been extensively researched for cancer prevention and therapy.
• Despite progress, clinical development of promising antioxidant agents requires further focused efforts.

Discussion:

• Developing effective antioxidant therapies necessitates defining/validating new targets, identifying novel agents, and assessing their efficacy, safety, metabolism, and bioavailability.
• The debate continues on whether whole foods or single antioxidant agents are superior for cancer prevention, with dietary phytochemicals showing potential to enhance nutrient bioavailability and target multiple pathways.
• Target-based agent development often overlooks the importance of selecting an appropriate patient population, as specific targets may not be suitable for everyone.

Key Insights:

• Multidisciplinary collaboration is essential for advancing antioxidant agents from laboratory research to clinical application.
• Efficient clinical development requires rapid 'phase 0' trials to quickly identify and eliminate agents with low clinical potential.
• Personalized medicine approaches are needed to match specific antioxidant targets with appropriate patient populations.

Outlook:

• Future research should prioritize validating new targets and rigorously assessing novel antioxidant agents in preclinical models before human trials.
• Clinical trials must be carefully designed, focusing on appropriate populations and incorporating strategies to evaluate efficacy and safety.
• Integrating insights from nutritional science and whole foods research may offer synergistic benefits in antioxidant-based cancer prevention and treatment strategies.